Compile Data Set for Download or QSAR
Report error Found 59 Enz. Inhib. hit(s) with Target = 'Pyruvate kinase PKLR'
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM719702(6-((1H-pyrazol-4-yl)sulfonyl)-2-((1-cyclopropyl-1H...)
Affinity DataEC50:  10.3nMAssay Description:Human PKLR was diluted into Assay Buffer to a final concentration of 5 pM. Enzyme-Assay Buffer mix was dispensed into 384-well shallow-well white-wal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50016876(CHEMBL3278432)
Affinity DataKd:  3.60E+7nMAssay Description:Binding affinity to Sprague-Dawley rat pyruvate kinase L assessed as apprent enzyme-inhibitor dissociation constant using PEP as substrate by spectro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2015
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50638113(CHEMBL5532261)
Affinity DataEC50:  290nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50597714(Mitapivat | Ag-348 | Pkr-in-1 | AG-348 | MITAPIVAT...)
Affinity DataEC50:  32.1nMAssay Description:Human PKLR was diluted into Assay Buffer to a final concentration of 5 pM. Enzyme-Assay Buffer mix was dispensed into 384-well shallow-well white-wal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50620644(CHEMBL5427010)
Affinity DataEC50:  1.39E+3nMAssay Description:Activation of purified human PLK (unknown origin) assessed as ATP production by Kinase-Glo Max luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50215545(CHEMBL6338)
Affinity DataIC50: 28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM4078(Elagic Acid | CHEMBL6246 | 6,7,13,14-tetrahydroxy-...)
Affinity DataIC50: 32nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50637646(CHEMBL5556210)
Affinity DataIC50: 70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50620645(CHEMBL5429790)
Affinity DataIC50: 120nMAssay Description:Inhibition of purified human PLK (unknown origin) assessed as ATP production by Kinase-Glo Max luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596765(CHEMBL5204170)
Affinity DataIC50: 150nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596761(CHEMBL5209097)
Affinity DataIC50: 160nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596768(CHEMBL5208105)
Affinity DataIC50: 200nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596751(CHEMBL5176753)
Affinity DataIC50: 200nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50143419(Sodium; 3,4-dihydroxy-9,10-dioxo-9,10-dihydro-anth...)
Affinity DataIC50: 200nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596767(CHEMBL5176181)
Affinity DataIC50: 290nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596760(CHEMBL5181251)
Affinity DataIC50: 300nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50637647(CHEMBL4754666)
Affinity DataIC50: 410nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596766(CHEMBL5204537)
Affinity DataIC50: 550nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596759(CHEMBL5188496)
Affinity DataIC50: 700nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596755(CHEMBL5183208)
Affinity DataIC50: 900nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596756(CHEMBL5186564)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596773(CHEMBL5195754)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596764(CHEMBL5206382)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596757(CHEMBL5186706)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596771(CHEMBL5181273)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596772(CHEMBL5200212)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596763(CHEMBL5198643)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50336799(Suramin hexasodium | Germanin | suramin | 8,8'-[Ca...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of PKL (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596774(CHEMBL5177546)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596770(CHEMBL5170574)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596775(CHEMBL5169856)
Affinity DataIC50: 3.80E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50271046(CHEMBL4127005)
Affinity DataIC50: 3.80E+3nMAssay Description:Inhibition of recombinant human N-terminal His-tagged PKL expressed in Escherichia coli preincubated for 15 mins followed by PEP/NADH addition measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2020
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596758(CHEMBL5172724)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596762(CHEMBL5170819)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596752(CHEMBL5172682)
Affinity DataIC50: 5.80E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596769(CHEMBL5193313)
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596753(CHEMBL5209293)
Affinity DataIC50: 7.50E+3nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50271043(CHEMBL4128703)
Affinity DataIC50: 8.20E+3nMAssay Description:Inhibition of recombinant human N-terminal His-tagged PKL expressed in Escherichia coli preincubated for 15 mins followed by PEP/NADH addition measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2020
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50029022(CHEMBL3339205)
Affinity DataIC50: 1.82E+4nMAssay Description:Inhibition of purified human N-terminal His-tagged PK-R by LDH-coupled continuous assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2016
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50596754(CHEMBL5188932)
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of PKL (unknown origin) for 30 mins by Kinase-Glo Max reagent based luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50029022(CHEMBL3339205)
Affinity DataIC50: 2.15E+4nMAssay Description:Inhibition of purified human N-terminal His-tagged PK-L by LDH-coupled continuous assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2016
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50033731(5,8-Dihydroxy-2-(1-hydroxy-4-methyl-pent-3-enyl)-[...)
Affinity DataIC50: 3.93E+4nMAssay Description:Inhibition of recombinant human N-terminal His-tagged PKL expressed in Escherichia coli preincubated for 15 mins followed by PEP/NADH addition measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2020
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Human)
Sitryx Therapeutics

US Patent
LigandPNGBDBM50336799(Suramin hexasodium | Germanin | suramin | 8,8'-[Ca...)
Affinity DataKi:  1.10E+3nMAssay Description:Binding affinity to PKL (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50367051(CHEMBL606059)
Affinity DataKi:  2.20E+6nMAssay Description:Inhibitory constant for inhibition of pyruvate kinase obtained from rat liver (PK-L) was determined using ADP as competitive inhibitorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50367054(CHEMBL606476)
Affinity DataKi:  8.40E+6nMAssay Description:Inhibition of rat liver pyruvate kinase (PK-L) at 3.6 mMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50367053(CHEMBL605428)
Affinity DataKi:  7.50E+6nMAssay Description:Inhibition of rat liver pyruvate kinase (PK-L) at 3.6 mMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50028625([5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-methoxytetr...)
Affinity DataKi:  7.00E+6nMAssay Description:Inhibition of rat liver pyruvate kinase (PK-L) at 3.6 mMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50367052(CHEMBL605425)
Affinity DataKi:  1.60E+6nMAssay Description:Inhibition of rat kidney pyruvate kinase (PK-L)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50367050(CHEMBL606006)
Affinity DataKi:  1.09E+7nMAssay Description:Inhibition of rat kidney pyruvate kinase (PK-K) at 6.7 mMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
TargetPyruvate kinase PKLR(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50367051(CHEMBL606059)
Affinity DataKi:  2.90E+6nMAssay Description:Inhibition of rat kidney pyruvate kinase (PK-K)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: